Literature DB >> 17230406

A study of risk factors for acquisition of Epstein-Barr virus and its subtypes.

Craig D Higgins1, Anthony J Swerdlow, Karen F Macsween, Nadine Harrison, Hilary Williams, Karen McAulay, Ranjit Thomas, Stuart Reid, Margaret Conacher, Kathryn Britton, Dorothy H Crawford.   

Abstract

BACKGROUND: Risk factors for primary infection with Epstein-Barr virus (EBV) and its subtypes have not been fully investigated.
METHODS: Questionnaires and serum samples from a total of 2006 students who entered Edinburgh University in 1999-2000 were analyzed to examine risk factors for EBV seropositivity, both overall and by EBV type.
RESULTS: The prevalence of EBV seropositivity was significantly increased among females, older students, those who had lived in tropical countries, those with siblings, and those who were sexually active, particularly if they had had numerous sex partners. Risk was lower (1) among students who always used a condom than among those who had sexual intercourse without one and (2) among female oral-contraceptive users than among sexually active nonusers. Risk factors for type 1 EBV infection were similar to those for EBV overall. No associations were found between nonsexual risk factors and type 2 infection. Sexual activity increased the risk of type 2 infection, but the increase in risk with number of sex partners was less consistent than for type 1 infections. Dual infection was uncommon, but the patterns of risk appeared to be similar to those of type 1 infection.
CONCLUSION: This study provides further evidence that EBV may be sexually transmitted and some suggestion that the risk factors for type 1 and type 2 infection differ.

Entities:  

Mesh:

Year:  2007        PMID: 17230406     DOI: 10.1086/510854

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Authors:  Peter A Maple; Alberto Ascherio; Jeffrey I Cohen; Gary Cutter; Gavin Giovannoni; Claire Shannon-Lowe; Radu Tanasescu; Bruno Gran
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

Review 3.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

4.  A large-scale seroprevalence of Epstein-Barr virus in Taiwan.

Authors:  Chao-Yu Chen; Kuan-Ying A Huang; Jen-Hsiang Shen; Kuo-Chien Tsao; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

Review 5.  Host genetics of Epstein-Barr virus infection, latency and disease.

Authors:  Charlotte J Houldcroft; Paul Kellam
Journal:  Rev Med Virol       Date:  2014-11-27       Impact factor: 6.989

6.  Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.

Authors:  Lucy Pembrey; Pauline Raynor; Paul Griffiths; Shelley Chaytor; John Wright; Andrew J Hall
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Frequency of Epstein - Barr Virus in Patients Presenting with Acute Febrile Illness in Kenya.

Authors:  Clement Masakhwe; Horace Ochanda; Nancy Nyakoe; Daniel Ochiel; John Waitumbi
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

8.  Associations Between Salivary Bacteriome Diversity and Salivary Human Herpesvirus Detection in Early Childhood: A Prospective Cohort Study.

Authors:  Freida Blostein; Sydney Foote; Elizabeth Salzman; Daniel W McNeil; Mary L Marazita; Emily T Martin; Betsy Foxman
Journal:  J Pediatric Infect Dis Soc       Date:  2021-09-23       Impact factor: 5.235

9.  Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.

Authors:  Nora Mutalima; Elizabeth Molyneux; Harold Jaffe; Steve Kamiza; Eric Borgstein; Nyengo Mkandawire; George Liomba; Mkume Batumba; Dimitrios Lagos; Fiona Gratrix; Chris Boshoff; Delphine Casabonne; Lucy M Carpenter; Robert Newton
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

10.  The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak.

Authors:  Elizabeth Visser; Denis Milne; Ian Collacott; David McLernon; Carl Counsell; Mark Vickers
Journal:  BMC Infect Dis       Date:  2014-03-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.